Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Sales | 9,014 | 18,588 | 0 | 0 | 0 |
| Gross Profit | 9,014 | 18,588 | N/A | N/A | N/A |
| Operating Expenses | 55,457 | 34,525 | 0 | 0 | 0 |
| Operating Income | -46,443 | -15,937 | N/A | N/A | N/A |
| Interest Expense | 3,106 | 303 | 0 | 0 | 0 |
| Other Income | 12,268 | 2,495 | 0 | 0 | 0 |
| Pre-tax Income | -37,281 | -13,745 | 0 | 0 | 0 |
| Income Tax | -724 | -907 | N/A | N/A | N/A |
| Net Income Continuous | -36,557 | -12,838 | N/A | N/A | N/A |
| Net Income | $-36,557 | $-12,838 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -1.54 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -1.54 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1.54 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -1.54 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-45,823 | $-15,267 | $N/A | $N/A | $N/A |